Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors

Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors

US Patent 7479491 · Granted Jan 20, 2009

Estimated economic value: $112,505,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystal forms of the monosodium salt of foramsulfuron2023
Anti-αβTCR antibody2021
Methods for enhancing immunosuppressive therapy by multiple administration of αβ2021
Crystal forms of the monosodium salt of foramsulfuron2019
Anti-αβTCR antibody2018
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2016
Binder-drug conjugates (ADCs) and use thereof2015
Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferat2014
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2014
Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising sam2014
Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising sam2014
Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising 2013